Moreover, our in vitro analysis further clarified that LAT1 suppression in CRC cells increased oxaliplatin sensitivity via suppression of oxaliplatin-induced p-mTOR and p-p70S6K. This evidence concerns the gene LAT and colorectal carcinoma.